A Phase I study of an HLA-DPB1*0401-restricted T cell receptor targeting MAGE-A3 for patients with metastatic cancers
Yong-Chen Lu, Linda Parker, Tangying Lu, Zhili Zheng, Xin Yao, Paul F Robbins, Pierre van der Bruggen, Christopher A Klebanoff, Christian S Hinrichs, Stephanie Goff, Richard Sherry, Udai Kammula, James C Yang, Steven A Rosenberg
Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P158; DOI: 10.1186/2051-1426-3-S2-P158